Therapeutic inhibitors of GDF15 signalling
MYPI2026004923A0Undetermined Publication Date: 2022-09-30KYMBA LIMITED +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2026004923
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-03-31
- Filing Date
- 2022-03-31
- Publication Date
- 2022-09-30
Abstract
This invention relates to antibodies that bind to and inhibit the activity of glial cell-derived neurotrophic factor family receptor alpha like (GFRAL) protein. The invention also relates to the GDF15-GFRAL signalling pathway as a therapeutic target for states of cachexia and conditions involving reduction in food intake and reduction in muscle and fat mass.
Need to check novelty before this filing date? Find Prior Art
